Skip to main content
Justin Bailey, MD, Infectious Disease, Baltimore, MD

Justin Richard Bailey MD


Assistant Professor of Medicine, Johns Hopkins University School of Medicine

Join to View Full Profile
  • 1717 E Monument StBaltimore, MD 21287

  • Phone+1 410-955-1725

  • Fax+1 410-500-4266

Dr. Bailey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Infectious Disease, 2009 - 2012
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2007 - 2010
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2007

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2010 - 2026
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Publications & Presentations

PubMed

Journal Articles

  • CMPK2 and BCL-G Are Associated with Type 1 Interferon–Induced HIV Restriction in Humans  
    Justin R. Bailey, Joel N. Blankson, Robert F. Siliciano, Stuart C. Ray, Ramy El-Diwany, Science Magazine

Grant Support

  • Molecular and structural characterization of broadly neutralizing anti-HCV antibodiesJOHNS HOPKINS UNIVERSITY2023–2028
  • Molecular and structural characterization of broadly neutralizing anti-HCV antibodiesJOHNS HOPKINS UNIVERSITY2023–2028
  • The role of neutralizing antibodies in natural and treatment-induced control of hepatitis B with and without HIV-1 co-infectionJOHNS HOPKINS UNIVERSITY2023–2027
  • The role of neutralizing antibodies in natural and treatment-induced control of hepatitis B with and without HIV-1 co-infectionJOHNS HOPKINS UNIVERSITY2023–2027
  • Neutralizing antibody responses during natural control of acute hepatitis B with and without HIV-1 coinfectionJOHNS HOPKINS UNIVERSITY2022–2026
  • Development of standardized immunoassays and virus panels for HCV vaccine researchJOHNS HOPKINS UNIVERSITY2021–2025

Other Languages

  • German

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: